当前位置: X-MOL 学术Eur. J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Targeting fungal virulence factor by small molecules: Structure-based discovery of novel secreted aspartic protease 2 (SAP2) inhibitors.
European Journal of Medicinal Chemistry ( IF 6.0 ) Pub Date : 2020-06-21 , DOI: 10.1016/j.ejmech.2020.112515
Chenglan Li 1 , Yang Liu 2 , Shanchao Wu 3 , Guiyan Han 3 , Jie Tu 3 , Guoqiang Dong 3 , Na Liu 3 , Chunquan Sheng 1
Affiliation  

Secreted aspartic protease 2 (SAP2), a kind of virulence factor, is an emerging new antifungal target. Using docking-based virtual screening and structure-based inhibitor design, a series of novel SAP2 inhibitors were successfully identified. Among them, indolone derivative 24a showed potent SAP2 inhibitory activity (IC50 = 0.92 μM). It blocked fungi biofilm and hypha formation by down-regulating the expression of genes SAP2, ECE1, ALS3 and EFG1. As a virulence factor inhibitor, compound 24a was inactive in vitro and showed potent in vivo efficacy in a murine model of invasive candidiasis. It represents a promising lead compound for the discovery of novel antifungal agents.



中文翻译:

小分子靶向真菌毒性因子:新型分泌天冬氨酸蛋白酶2(SAP2)抑制剂的基于结构的发现。

分泌的天冬氨酸蛋白酶2(SAP2)是一种毒性因子,是一种新兴的抗真菌靶标。使用基于对接的虚拟筛选和基于结构的抑制剂设计,成功鉴定了一系列新型SAP2抑制剂。其中,吲哚酮衍生物24a显示出有效的SAP2抑制活性(IC 50 = 0.92μM)。它通过下调SAP2ECE1ALS3EFG1基因的表达来阻止真菌生物膜和菌丝的形成。作为毒力因子抑制剂,化合物24a在体外侵袭性念珠菌病的鼠模型中显示出强效的体内活性。它代表了发现新型抗真菌剂的有前途的先导化合物。

更新日期:2020-06-23
down
wechat
bug